Skip to main content
Midas Edge

Boundless Bio, Inc.

For the period ended Jun 30, 2026. Filed Aug 7, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 7, 2026

BOLD$2.45-0.4%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Condensed Statements of Stockholders’ Equity

(in thousands)

Common Stock · Additionalpaid-in · Accumulatedother comprehensive · Accumulated · Total stockholders'
SharesAmountcapitalincome/ (loss)deficitequity
Balance at December 31, 202522,407$2$358,257$64$(259,669)$98,654
Stock-based compensation——1,371——1,371
Unrealized loss on short-term investments———(87)—(87)
Net loss————(13,555)(13,555)
Balance at March 31, 202622,407$2$359,628$(23)$(273,224)$86,383
Stock-based compensation——3,222——3,222
Issuance of common stock under the Employee Stock Purchase Plan35—37——37
Exercise of stock options33—36——36
Unrealized loss on short-term investments———(9)—(9)
Net loss————(23,693)(23,693)
Balance at June 30, 202622,475$2$362,923$(32)$(296,917)$65,976
Balance at December 31, 202422,300$2$351,991$121$(201,472)$150,642
Stock-based compensation——1,797——1,797
Unrealized loss on short-term investments———(89)—(89)
Net loss————(15,758)(15,758)
Balance at March 31, 202522,300$2$353,788$32$(217,230)$136,592
Stock-based compensation——1,693——1,693
Issuance of common stock under the Employee Stock Purchase Plan86—117——117
Unrealized loss on short-term investments———(36)—(36)
Net loss————(15,675)(15,675)
Balance at June 30, 202522,386$2$355,598$(4)$(232,905)$122,691
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.